Astrea Sunovis is developing a nanotech biosensor for painless oral cancer screening
Dr. Jayanthi · 17 Young Founders | 8 Startups | 20 Lakh Grants | Third WTFund Cohort · Nikhil Kamath · Jan 28, 2026 · at 10:30
Dr. Jayanthi, founder of Astrea Sunovis, pitches her startup at the WTFund cohort retreat hosted by Nikhil Kamath.
0:00 / 0:10exact quote · 10.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“And we're developing Onkoalat. It is IVD, it's a nanotech-based biosensing platform for early, easy, painless, needleless detection of oral cancer.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Dr. Jayanthi
Dr. Jayanthi: Visual naked-eye screening for oral cancer is only 60% accurate
“The detection of oral cancer currently is just visual screen, naked eyes. There's no tool, there's no devices, you are just supposed to look with naked eyes and detect microscopic changes. That is, that's why the accuracy rate is almost as good as a flip of a …”